{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:23:25Z","timestamp":1775780605388,"version":"3.50.1"},"reference-count":56,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T00:00:00Z","timestamp":1108944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>We recently reported that virtually all children with acute leukaemia and myelodysplastic syndrome (MDS) who develop the phenotype of increasing mixed chimaerism (MC) after allogeneic stem cell transplantation (allo\u2010SCT) will relapse. We therefore performed a prospective, multi\u2010centre study focused on children with MDS (<jats:italic>n<\/jats:italic>\u2003=\u200365; advanced MDS\u2003=\u200344, refractory cytopenia\u2003=\u200321) after allo\u2010SCT in order to determine to what extent relapse can be prevented by pre\u2010emptive immunotherapy on the basis of increasing MC. Analyses of chimaerism in 44 patients with advanced MDS revealed 31 cases with complete chimaerism (CC)\/low\u2010level MC\/transient MC, 11 cases with increasing MC and two cases with decreasing MC. The same analyses in 21 MDS patients with refractory cytopenia revealed 17 cases with CC\/low\u2010level MC, one case with increasing MC and three cases with decreasing MC. Pre\u2010emptive immunotherapy performed on each patient that showed increasing MC improved event\u2010free survival from 0%, as seen in prior studies, to 50%. We therefore conclude that pre\u2010emptive immunotherapy is an effective treatment option to prevent impending relapse in children with MDS after allo\u2010SCT.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2004.05354.x","type":"journal-article","created":{"date-parts":[[2005,2,21]],"date-time":"2005-02-21T12:55:49Z","timestamp":1108990549000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre\u2010emptive immunotherapy"],"prefix":"10.1111","volume":"128","author":[{"given":"Peter","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Niemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Willasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Kreyenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Strahm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Kremens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Gruhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Dilloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Vormoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietrich","family":"Niethammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klingebiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,2,21]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700961"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700762"},{"key":"e_1_2_14_4_1","first-page":"1759","article-title":"Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT","volume":"16","author":"Bader P.","year":"1996","journal-title":"Anticancer Research"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700721"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700831"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701119"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401581"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01927.x"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.198"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704444"},{"key":"e_1_2_14_12_1","article-title":"How and when should we monitor chimersm after allogeneic stem cell transplantation","author":"Bader P.","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb08083.x"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400546"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.16.3675"},{"key":"e_1_2_14_16_1","first-page":"391","article-title":"Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft\u2010versus\u2010leukemia effect following abrupt discontinuation of immunosuppression","volume":"10","author":"Collins R.H.","year":"1992","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.2.433"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09105-2"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-197410000-00001"},{"key":"e_1_2_14_20_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V73.2.619.619","article-title":"Bone marrow transplantation for children with myelodysplastic syndromes","volume":"73","author":"Guinan E.C.","year":"1989","journal-title":"Blood"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402765"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609054857"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.11.3302.bloodjournal85113302"},{"key":"e_1_2_14_24_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"58","author":"Kaplan E.","year":"1958","journal-title":"Journal of Statistical Association"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-11-3444"},{"key":"e_1_2_14_26_1","first-page":"S45","article-title":"GVHD: overview on pathophysiology, incidence, clinical and biological features","volume":"21","author":"Klingebiel T.","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402315"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1998.tb05438.x"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199703000-00006"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.12.2462.2462"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402761"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701517"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402017"},{"key":"e_1_2_14_35_1","first-page":"844","article-title":"Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes","volume":"8","author":"Locatelli F.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_14_36_1","first-page":"63","article-title":"Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG\u2010MDS) and the Austria\u2010Germany\u2010Italy (AGI) Bone Marrow Transplantation Registry","volume":"18","author":"Locatelli F.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900205"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V86.4.1261.bloodjournal8641261"},{"key":"e_1_2_14_39_1","first-page":"591","article-title":"Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response","volume":"15","author":"Mackinnon S.","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0506"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402311"},{"key":"e_1_2_14_42_1","first-page":"133","article-title":"Cytokine\u2010mediated immunotherapy with or without donor leukocytes for poor\u2010risk acute myeloid leukemia relapsing after allogeneic bone marrow transplantation","volume":"16","author":"Mehta J.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700720"},{"key":"e_1_2_14_44_1","first-page":"331","article-title":"Second allogeneic hematopoietic stem cell transplantation in hematologic malignancies in children: long\u2010term results of a multicenter study of the Spanish Working Party for Bone Marrow Transplantation in Children (GETMON)","volume":"87","author":"Munoz A.","year":"2002","journal-title":"Haematologica"},{"key":"e_1_2_14_45_1","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1182\/blood.V87.9.4020.bloodjournal8794020","article-title":"Long\u2010term follow\u2010up of 12 pediatric patients with primary myelodysplastic syndrome treated with HLA\u2010identical sibling donor bone marrow transplantation","volume":"87","author":"Nichols K.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_14_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002371-199811000-00007"},{"key":"e_1_2_14_47_1","first-page":"979","article-title":"Immunotherapy with donor leukocyte infusions for patients with relapsed acute myeloid leukemia following partially mismatched related donor bone marrow transplantation","volume":"15","author":"Pati A.R.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_48_1","first-page":"975","article-title":"Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation","volume":"18","author":"Porter D.L.","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1234"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.11.3377.3377"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900204"},{"key":"e_1_2_14_52_1","first-page":"759","article-title":"Intensified conditioning regimen with busulfan followed by allogeneic BMT in children with myelodysplastic syndromes","volume":"13","author":"Rubie H.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199305000-00006"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950210109"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90871-5"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02200.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2004.05354.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2004.05354.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:31:46Z","timestamp":1697416306000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2004.05354.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,21]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1365-2141.2004.05354.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2004.05354.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,21]]},"assertion":[{"value":"2005-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}